Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Recruiting now NCT05804578
Run by Dr. Christopher Mueller · for 18 and older · Women
What this study is about
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
Who can join (things the study team will check)
Inclusion Criteria -Adult women (≥ 18 years of age) with proven diagnosis of adenocarcinoma of the breast with evidence of recurrent or metastatic disease not amenable to resection or radiation therapy with curative intent \[to be herein described as 'metastatic'\]…
Where this trial is running
- Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada
- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Who to contact
Christopher R Mueller, Ph.D. · 613-533-6751 · muellerc@queensu.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05804578.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.